Sab, LLC
Records under this name other than the patents Sab, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,928,285 | Method of producing xenogenous antibodies using a bovine Term ended Term ended Nov 5, 2025 · From the USPTO record | Term ended | Term ended Nov 5, 2025 | From the USPTO record |
| US 7,429,690 | Transgenic bovines having reduced prion protein production Term ended Term ended Jul 30, 2024 · From the USPTO record | Term ended | Term ended Jul 30, 2024 | From the USPTO record |
| US 7,491,534 | Methods for altering cell fate to generate T-cells specific for an antigen of interest Term ended Term ended Mar 29, 2024 · From the USPTO record | Term ended | Term ended Mar 29, 2024 | From the USPTO record |
| US 7,807,863 | Transgenic bovine having reduced prion protein activity and uses thereof Term ended Ended no later than Nov 10, 2023 · From the USPTO record | Term ended | Ended no later than Nov 10, 2023 | From the USPTO record |
| US 7,652,192 | Cloning of transgenic unglulates comprising artificial chromosomes Term ended Term ended Jun 7, 2023 · From the USPTO record | Term ended | Term ended Jun 7, 2023 | From the USPTO record |
| US 7,253,334 | Methods for cloning non-human mammals using reprogrammed donor chromatin or donor cells Term ended Term ended Jan 29, 2023 · From the USPTO record | Term ended | Term ended Jan 29, 2023 | From the USPTO record |
| US 7,803,981 | Transgenic ungulates capable of human antibody production Term ended Term ended Aug 14, 2021 · From the USPTO record | Term ended | Term ended Aug 14, 2021 | From the USPTO record |
| US 7,820,878 | Production of ungulates, preferably bovines that produce human immunoglobulins Term ended Term ended Feb 18, 2021 · From the USPTO record | Term ended | Term ended Feb 18, 2021 | From the USPTO record |
| US 7,491,867 | Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates Term ended Term ended Feb 9, 2021 · From the USPTO record | Term ended | Term ended Feb 9, 2021 | From the USPTO record |
| US 7,074,983 | Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin Formerly held Term ended Term ended Jan 24, 2021 · From the USPTO record | Term ended | Term ended Jan 24, 2021 | From the USPTO record |